Search - tctmd.com

Displaying 521 - 540 of 3032

Sort: Relevancy | Date

Presentation TCT 2023

What Should EFS 2.0 Look Like?

Presenter: Aaron Kaplan

October 24, 2023

Presentation TCT 2023

Cognitive AI and Computer Vision to Detect Acute Cardiac Conditions Using Facial Analysis (MiaVitalis)

Presenter: Issam Moussa

October 24, 2023

Presentation TCT 2023

MDIC and EFS: The Good, the Bad, and the Ugly (Case Examples)

Presenter: Chip Hance

October 24, 2023

Presentation TCT 2023

Viewpoints From Europe

Presenter: Stephan Windecker

October 24, 2023

Presentation TCT 2023

Continuous Non-Invasive Biological Sample Biomarkers for Chronic Disease Monitoring (GPX)

Presenter: Javier Echenique

October 24, 2023

Presentation TCT 2023

Predicting Ischemic and Bleeding Risk in Patients after PCI on DAPT: An Individualized Patient Centered Machine Learning Model

Presenter: Roxana Mehran

October 24, 2023

Presentation TCT 2023

Heart Valve Collaboratory

Presenter: Martin Leon

October 24, 2023

Presentation TCT 2023

EP Consortium

Presenter: Peter Weiss

October 24, 2023

Presentation TCT 2023

A 10-Year Perspective—Lessons Learned

Presenter: Andrew Farb

October 24, 2023

Presentation TCT 2023

Immediate and Follow-Up Outcomes of Drug-Coated Balloon Angioplasty in de Novo Long Lesions on Large Coronary Arteries

Presenter: Pier Pasquale Leone

October 24, 2023

Presentation TCT 2023

Drug-Coated Balloon Angioplasty For De Novo Lesions on Left Anterior Descending Artery

Presenter: Mauro Gitto

October 24, 2023

Presentation TCT 2023

FDA Opinion About Lessons Learned From the PTX Controversy

Presenter: Eleni Whatley

October 24, 2023

Presentation TCT 2023

Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: The DEBuT-LRP Study

Presenter: Bimmer Claessen

October 24, 2023

Presentation TCT 2023

Drug-Coated Balloon for Acute Coronary Syndromes: A Multicenter Randomized Non-inferiority Trial (DCB-ACS Trial)

Presenter: Haibo Jia

October 24, 2023

Presentation TCT 2023

State of the FDA CDRH: Challenges, Opportunities, and Future Projections for Device Innovation, Approval, and Implementation

Presenter: Bram Zuckerman

October 24, 2023

Presentation TCT 2023

A Prospective, Multicenter, Randomized Trial Comparing Sirolimus-Coated Balloon with Paclitaxel-Coated Balloon in De-Novo Small Vessels: The TRANSFORM I Trial

Presenter: Patrick Serruys

October 24, 2023

Presentation TCT 2023

Treatment of Coronary De-Novo Lesions by a Sirolimus or a Paclitaxel Coated Balloon in a European Population

Presenter: Bruno Scheller

October 24, 2023

Presentation TCT 2023

Twelve-Month Follow-Up Outcomes of a Prospective, Multi-Center, Open, Single-Arm Study of the First Everolimus-Coated Balloon for the Treatment of Coronary In-Stent Restenosis

Presenter: Manel Sabate

October 24, 2023

News Daily News

FDA Approves First Extravascular ICD

Yael L. Maxwell

October 23, 2023

Presentation TCT 2023

The Total Product Lifecyle Advisory Program: A Closer Partnership with FDA

Presenter: Kimberly Ferlin

October 23, 2023

Advertisement

What Should EFS 2.0 Look Like?

Cognitive AI and Computer Vision to Detect Acute Cardiac Conditions Using Facial Analysis (MiaVitalis)

MDIC and EFS: The Good, the Bad, and the Ugly (Case Examples)

Viewpoints From Europe

Continuous Non-Invasive Biological Sample Biomarkers for Chronic Disease Monitoring (GPX)

Predicting Ischemic and Bleeding Risk in Patients after PCI on DAPT: An Individualized Patient Centered Machine Learning Model

Heart Valve Collaboratory

EP Consortium

A 10-Year Perspective—Lessons Learned

Immediate and Follow-Up Outcomes of Drug-Coated Balloon Angioplasty in de Novo Long Lesions on Large Coronary Arteries

Drug-Coated Balloon Angioplasty For De Novo Lesions on Left Anterior Descending Artery

FDA Opinion About Lessons Learned From the PTX Controversy

Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: The DEBuT-LRP Study

Drug-Coated Balloon for Acute Coronary Syndromes: A Multicenter Randomized Non-inferiority Trial (DCB-ACS Trial)

State of the FDA CDRH: Challenges, Opportunities, and Future Projections for Device Innovation, Approval, and Implementation

A Prospective, Multicenter, Randomized Trial Comparing Sirolimus-Coated Balloon with Paclitaxel-Coated Balloon in De-Novo Small Vessels: The TRANSFORM I Trial

Treatment of Coronary De-Novo Lesions by a Sirolimus or a Paclitaxel Coated Balloon in a European Population

Twelve-Month Follow-Up Outcomes of a Prospective, Multi-Center, Open, Single-Arm Study of the First Everolimus-Coated Balloon for the Treatment of Coronary In-Stent Restenosis

FDA Approves First Extravascular ICD

The Total Product Lifecyle Advisory Program: A Closer Partnership with FDA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content